Hart & Hart represented Cel-Sci Corp. in the offering, and Sichenzia Ross Ference Carmel represented ThinkEquity LLC. CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase...
Cel-Sci Corp.’s $7.75 Million Initial Public Offering
Cel-Sci’s $5 Million Common Stock Offering
Hart & Hart represented CEL-SCI Corporation in the offering, and Sichenzia Ross Ference Carmel represented ThinkEquity. Cel-Sci (NYSE:CVM) announced its $5.0 million offering of 2,490,000 shares of...
Cerba Healthcare International’s Acquisition of CIRION BioPharma Research Inc.
Langlois Lawyers LLP acted on behalf of Cerba Healthcare International on the acquisition of CIRION BioPharma Research Inc. Cerba HealthCare, a leading global player in medical...